FDA approves first drug to specifically treat postpartum depression, but it isn't cheap

Zulresso, also known as brexanolone, has just been approved to treat postpartum depression by the U.S. Food and Drug Administration (FDA). This is the first drug ever approved to specifically assist women suffering from this mood disorder and the second new antidepressant treatment passed by the FDA this month, after the landmark approval of esketamine.

.. Continue Reading FDA approves first drug to specifically treat postpartum depression, but it isn't cheap

Category: Medical

Tags:

• Depression
• Drugs
• FDA
• Pregnancy

from New Atlas (Gizmag) https://ift.tt/2Fo0Fau
via IFTTT